CORRESP Filing
Kairos Pharma, LTD.
Date: Jan. 21, 2026 · CIK: 0001962011 · Accession: 0001493152-26-002996
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292686
Letter
KAIROS PHARMA LTD.
Westwood Blvd., #139
Los Angeles CA 90064
(818) 404-5541
January 21, 2026
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Kairos Pharma, Ltd.
Registration Statement on Form S-3
File No. 333-292686
Acceleration Request
Requested Date: January 23, 2026
Requested Time: 9:00 AM Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Kairos Pharma, Ltd. hereby requests acceleration of the effective date of its registration statement on Form S-3 (File No. 333-292686) so that it may become effective at 9:00 a.m. Eastern Time on January 23, 2026, or as soon thereafter as is practicable.
Very
truly yours,
Kairos
Pharma, Ltd.
Show Raw Text
CORRESP
1
filename1.htm
KAIROS
PHARMA LTD.
2355
Westwood Blvd., #139
Los
Angeles CA 90064
(818)
404-5541
January
21, 2026
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Kairos
Pharma, Ltd.
Registration
Statement on Form S-3
File
No. 333-292686
Acceleration
Request
Requested
Date:
January
23, 2026
Requested
Time:
9:00
AM Eastern Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Kairos Pharma, Ltd. hereby requests acceleration of the effective
date of its registration statement on Form S-3 (File No. 333-292686) so that it may become effective at 9:00 a.m. Eastern Time
on January 23, 2026, or as soon thereafter as is practicable.
Very
truly yours,
Kairos
Pharma, Ltd.
/s/
John S. Yu
Name:
John
S. Yu
Title:
Chief
Executive Officer and
Chairman
of the Board of Directors
cc:
Dorsey & Whitney LLP